← Back to Search

Intra-marrow penetrations for Ridge Augmentation

N/A
Recruiting
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This trial aims to compare the results of two different methods used during guided bone regeneration procedures after 6 months.

Who is the study for?
This trial is for individuals needing ridge augmentation, a dental procedure to rebuild the jawbone. Participants should be suitable candidates for guided bone regeneration but cannot have conditions that would interfere with bone healing or be taking medications affecting bone turnover.Check my eligibility
What is being tested?
The study is examining if making small holes in the jawbone (intra-marrow penetrations) during guided bone regeneration helps improve clinical and histologic outcomes after 6 months compared to not making these holes.See study design
What are the potential side effects?
Potential side effects may include discomfort at the site of surgery, swelling, bruising, infection risk, and possible delayed healing. The exact side effects will depend on individual patient responses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alveolar Ridge Height
Alveolar Ridge Width
Buccal Soft Tissue Thickness
Secondary outcome measures
Histomorphometric Measurements

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intra-marrow penetrationsExperimental Treatment1 Intervention
Twelve test patients will receive guided bone regeneration therapy with the use of intra-marrow penetrations prior to bone graft placement.
Group II: No Intra-marrow penetrationsActive Control1 Intervention
Twelve test patients will receive guided bone regeneration therapy without the use of intra-marrow penetrations prior to bone graft placement.

Find a Location

Who is running the clinical trial?

University of LouisvilleLead Sponsor
339 Previous Clinical Trials
76,656 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current number of participants being recruited for this medical research study?

"Affirmative. The details on clinicaltrials.gov highlight the current recruitment status of this trial. Initially shared on June 15, 2023, and last revised on April 7, 2024, the investigation aims to enroll a total of 24 participants at one designated site."

Answered by AI

Is the current investigation open for participant enrollment?

"Indeed, the details on clinicaltrials.gov specify that this particular research study is actively seeking participants. Initially shared on June 15th, 2023, it was last modified on April 7th, 2024. The trial aims to enroll a total of 24 patients at one location."

Answered by AI
~2 spots leftby Jun 2024